## Note
nid: 1462849289458
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#B&B::08_Endocrinology::03_Pancreas::04_Treatment_of_Diabetes, #AK_Step1_v11::#FirstAid::05_Pharmacology::03_Toxicities_&_Side_Effects::13_Sulfa_drugs, #AK_Step1_v11::#FirstAid::05_Pharmacology::04_Misc::01_Drug_names, #AK_Step1_v11::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_Mellitus_Therapy, #AK_Step1_v11::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_Mellitus_Therapy::Sulfonylureas, #AK_Step1_v11::#OME::14_Endocrine::05_Pancreas::03_Diabetes_Pharm, #AK_Step1_v11::#OME_banner::Clinical::07_Endocrinology::06_Outpatient_Diabetes, #AK_Step1_v11::#Physeo::09_Pharm::07_Endocrine::04_Sulfonylureas_and_Meglitinides, #AK_Step1_v11::#Pixorize::02_Biochem::23_Diabetes_Drugs::06_Second-Gen_Sylfonylureas, #AK_Step1_v11::#Pixorize::03_Pharm::07_Diabetes::Second-Gen_Sulfonylureas, #AK_Step1_v11::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::01_Insulin,_sulfonylureas,_meglitinides,_GLP-1_agonists,_DPP-4_inhibitors, #AK_Step1_v11::#UWorld::10000-99999::11000-11999::11565, #AK_Step1_v11::#UWorld::10000-99999::15000-15999::15881, #AK_Step1_v11::^Other::^HighYield::2-RelativelyHighYield, #AK_Step1_v11::^Systems::Endocrine::Pharmacology, #AK_Step2_v11::!Shelf::FM, #AK_Step2_v11::!Shelf::FM::no_dupes, #AK_Step2_v11::!Shelf::IM, #AK_Step2_v11::!Shelf::IM::no_dupes, #AK_Step2_v11::#OME::07_Endocrinology::05_Outpatient_Diabetes, #AK_Step2_v11::#OME_banner, #AK_Step2_v11::#Resources_by_rotation::FM::ome::endo::outpatient_dm, #AK_Step2_v11::#Resources_by_rotation::IM::ome::endo::outpatient_dm, #AK_Step2_v11::#Subjects::Endocrinology::06_Pancreas::Diabetes::*Management_REDO, #AK_Step2_v11::Original_decks::Dorian::fam::ome::endo::outpatient_dm, #AK_Step2_v11::Original_decks::Dorian::im::ome::endo::outpatient_dm
markdown: false

### Text
<div>
  What <u>drug class</u> do <b>glyburide</b>, <b>glimepiride</b>,
  and <b>glipizide</b> belong to?
</div>
<div>
  {{c1::2nd generation sulfonylureas}}
</div>

### Extra
<div>
  <i>may be given in smaller doses than 1st generation
  sulfonylureas, therefore less risk of hypoglycemia</i>
</div>
<div><img src="paste-190812512059945.jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-728576777256963.jpg">
<div><img src="paste-722838700949507.jpg"></div>
<div><img src="paste-96877282328579.jpg"><img src=
"paste-99097780420611.jpg"></div>

### Sketchy
<div>
  <i>Sketchy Pharmacology: Endocrine (diabetes)</i>
</div><img src="paste-684905549791233.jpg" class="resizer">
<img src="paste-a206fca05b7752af65553db20a50b54a54b2f5f5.png"
class="resizer"> <img src=
"paste-e6fbef453ec48f26a134a2ff64e65a49409e9c9e.png" class=
"resizer"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-gi-endocrine/videos/medical-pharmacology-gi-and-endocrine-diabetes-insulin-sulfonylureas-meglitinides-glp-1-agonists-dpp-4-inhibitors?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Insulin, sulfonylureas, meglitinides, GLP 1 agonists, DPP 4
inhibitors</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/endocrinology/outpatient-diabetes/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_6.png"></a>
</div>

### Additional Resources
<img src="paste-3cc4d8401f73aea33baf934cf6ac4532444d9112.png"
class="resizer">
<div>
  <i><img class="resizer" src="paste-566420286996481.jpg" style=
  ""></i>
</div>

### One by one

